Aileron Therapeutics Inc (ALRN)
3.79
-0.06
(-1.56%)
USD |
NASDAQ |
May 17, 16:00
3.79
0.00 (0.00%)
After-Hours: 20:00
Aileron Therapeutics Cash and Short Term Investments (Quarterly): 17.31M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 17.31M |
| September 30, 2023 | 12.07M |
| June 30, 2023 | 13.67M |
| March 31, 2023 | 16.72M |
| December 31, 2022 | 21.24M |
| September 30, 2022 | 25.48M |
| June 30, 2022 | 32.38M |
| March 31, 2022 | 38.08M |
| December 31, 2021 | 45.93M |
| September 30, 2021 | 52.23M |
| June 30, 2021 | 59.48M |
| March 31, 2021 | 63.35M |
| December 31, 2020 | 13.80M |
| September 30, 2020 | 14.12M |
| June 30, 2020 | 18.88M |
| Date | Value |
|---|---|
| March 31, 2020 | 12.70M |
| December 31, 2019 | 18.28M |
| September 30, 2019 | 24.56M |
| June 30, 2019 | 31.52M |
| March 31, 2019 | 13.27M |
| December 31, 2018 | 20.70M |
| September 30, 2018 | 27.94M |
| June 30, 2018 | 35.79M |
| March 31, 2018 | 43.29M |
| December 31, 2017 | 50.75M |
| September 30, 2017 | 56.86M |
| June 30, 2017 | 11.34M |
| March 31, 2017 | 15.29M |
| December 31, 2016 | 20.72M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
12.07M
Minimum
Sep 2023
63.35M
Maximum
Mar 2021
27.99M
Average
21.24M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| EyePoint Pharmaceuticals Inc | 299.35M |
| INVO Bioscience Inc | 0.2324M |
| Bio-Path Holdings Inc | 1.052M |
| SINTX Technologies Inc | 5.762M |
| NovaBay Pharmaceuticals Inc | 1.823M |